Adding Keytruda to chemotherapy improved progression-free survival in a subset of patients with cervical cancer.Patients with newly diagnosed, previously ...

For women with ductal carcinoma in situ (DCIS), adhering to a hormonal therapy regimen “is critical to minimizing the occurrence of developing subsequent ...

Obesity was associated with an increased recurrence risk for patients with postmenopausal HR-positive early-stage breast cancer that was treated with ...

The journey through multiple myeloma, a cancer of plasma cells, is a challenging one, filled with numerous ups and downs. It is an odyssey that tests one's ...

The road to recovery  Having been in the enviable position of working with so many great artists worldwide as a professional drummer, Mark worried his ...

Patients with hormone receptor-positive, HER2-negative high-risk early breast cancer with disease in their lymph nodes experienced continued invasive ...

Different perspectives are key Speaking to Richard and Peter about their Project Award, it’s interesting to hear how their scientific backgrounds shape ...

In part one of CURE’s “Radiance Unveiled: Skincare and Makeup Strategies Throughout Breast Cancer Treatment” webinar, Rudy Miles, a 10-year Look Good Feel ...

Expert oncologists offer closing thoughts on emerging therapeutic strategies, unmet needs, and the future of kidney cancer treatment.

Mind the gap during The latest figures from NHS England (2021-2022) for cervical screening show that almost a third (30%) of eligible people ...

Patients with HER2-positive metastatic breast cancer with both stable and active brain metastases treated with Enhertu (fam-trastuzumab deruxtecan-nxki) ...

Across nearly two decades of working in oncology, Dr. Timothy M. Pawlik has seen attitudes regarding palliative care evolve first-hand.“It would be very ...